Tuesday, March 18, 2014
(Undated) -- A California drug maker says its new cholesterol drug could work wonders in people genetically predisposed to high cholesterol. Amgen Inc. says patients injected with AMG-145 once a month showed real improvement as opposed to taking statin drugs alone. The trial lasted for 12 weeks. It's not clear when the company will bring the drug to market.